Naroa Barrena

8PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer geneticsTumour immunologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 05, 2026
IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

|Jan 12, 2026
Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention set.

Naroa Barrena, Carlos Rodriguez-Flores, Luis V Valcárcel

|Oct 11, 2024
An automated network-based tool to search for metabolic vulnerabilities in cancer.

Luis V Valcárcel, Edurne San José-Enériz, Raquel Ordoñez

|Sep 25, 2024
PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma.

Laura Martinez-Verbo, Yoana Veselinova, Pere Llinàs-Arias

|Jul 02, 2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal

|May 15, 2024
gMCSpy: efficient and accurate computation of genetic minimal cut sets in Python.

Carlos J Rodriguez-Flores, Naroa Barrena, Danel Olaverri-Mendizabal

Pageof 2

Frequent Collaborators

5 joint publications

Danel Olaverri-Mendizabal

5 joint publications

Francisco J Planes

5 joint publications

Luis V Valcárcel

4 joint publications

Felipe Prósper